Studien | Der Arzneimittelbrief

AFASAK 2

Copenhagen Atrie Flimmer ASpirin AntiKoagulation study 2

AFCAPS

Air Force Coronary Atherosclerosis Prevention Study

AFCKDI

Asian Forum for Chronic Kidney Disease Initiatives

AFEQT

Atrial Fibrillation Effect on QualiTy-of-Life

AFFECT-2

Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT

AFFECT-EU

General practitioners' perceptions on opportunistic single-time point screening for atrial fibrillation: A European quantitative survey

AFFINITY

Assessment oF FluoxetINe In sTroke recoverY

AFFINITY

Atrasentan in Patients With Proteinuric Glomerular Diseases

AFFINITY

Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel

AFFIRM

Atrial Fibrillation Follow-up Investigation of Rhythm Management

AFFIRM

NAtalizumab safety and eFFicacy in Relapsing remitting Multiple sclerosis study

AFFIRM

Promoting Awareness Fetal Movements to Reduce Fetal Mortality Stillbirth, a Stepped Wedge Cluster Randomised Trial

AFFIRM

Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy

AFFIRM

Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer

AFFIRM-AHF

Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency

AFFIRMO

Integrated Approach in Frail Older People with Atrial Fibrillation

AFIB

Atrial Fibrillation Investigation with Bidisomide

AFIRE

Atrial Fibrillation and Ischemic Events with Rivaroxaban in patients with stable coronary artery disease

AFIST III

Atrial Fibrillation Suppression Trial III

AFLOAT

Assessment of Flecainide to Lower the PFO closure risk of Atrial fibrillation or Tachycardia

AFORRD

Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes

AFR-PRELIEVE

Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction

AFRICARhE

Monoclonal RhD prophylaxis: high time to evaluate efficacy

AFRIM

Appropriate Fluid Resuscitation In Malnutrition

AFTER

Aspirin/Anticoagulants Following Thrombolysis with Eminase in Recurrent infarction

AfterROSC

Comparison of Scores for Early Brain Damage Assessment at Intensive Care Unit Admission After Out of Hospital Cardiac Arrest

AFTherapy

Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation

AFUGEM GERCOR

Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma

AGAIN

Arterial Glyceryl Trinitrate in Acute Ischemic Stroke after Thrombectomy for Neuroprotection

AGATA

Contribution of Contrast Enhanced Ultrasound in the Diagnosis of Adnexal Torsion

Impact of the Addition of a Device Providing Continuous Pneumatic Regulation of Tube Cuff Pressure to an Overall Strategy Aimed at Preventing Ventilator-associated Pneumonia in the Severe Trauma Patient

AGATHA

Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease

AGATHA-ME

Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease-Middle East

AGAVE-201

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

AGCH

Acute Geriatric Community Hospital in the Netherlands

AGCTG

Australian and New Zealand Germ Cell Trial Group

AgeCoDe

German study on Ageing, Cognition, and Dementia in primary care patients (1)

AgeCoDe

German study on Ageing, Cognition, and Dementia in primary care patients (2)

AgeCoDe

German study on Ageing, Cognition, and Dementia in primary care patients (3)

AGELESS

Multidomain Intervention for the Reversal of Cognitive Frailty Using a Personalized Approach

AGEN-T2D

Asian Genetic Epidemiology Network Type 2 Diabetes

AGENT

Angiogenic GENe Therapy

AGENT-2

Angiogene GENe Therapy-2: A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina

AGENT-3

Angiogenic GENe Therapy-3: Efficacy and Safety of Intracoronary Ad5FGF-4 in Patients With Stable Angina

AGENT-4

Angiogenic GENe Therapy-4: Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina

AGENT-ISR

Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis

AgeQualiDe

Bedarf und Inanspruchnahme von Versorgungsleistungen, direkte Kosten und gesundheitsbezogene Lebensqualität bei hochaltrigen Hausarztpatientinnen und -patienten (85+)

AGES

Aichi Gerontological Evaluation Study

AGGRASTENT

Early discharge is feasible following primary percutaneous coronary intervention with transradial stent implantation under platelet glycoprotein IIb/IIIa receptor blockade